Embryonal rhabdomyosarcoma of the uterine cervix in a 41-year-old woman treated with radical hysterectomy and adjuvant chemotherapy.
BACKGROUND
Cervical embryonal rhabdomyosarcoma (ERMS) mostly affects young girls. The current treatment protocols are based on trials done on patients under 21 years old. ERMS in women over 40 is rare, and studies on treatment and outcome are limited.


METHODS
We report a case of a 41 year-old woman with cervical ERMS who was treated with radical hysterectomy followed by chemotherapy. She is currently disease-free.


CONCLUSIONS
Cervical ERMS in women over the age of 40 can be treated using protocols established for the pediatric population.
Sanders
Mary Ann
MA
Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, Kentucky, USA.
Gordinier
Mary
M
Talwalkar
Sameer S
SS
Moore
Grace D
GD
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007044:Hysterectomy; D012208:Rhabdomyosarcoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide